Result of EGM

ValiRx PLC 02 May 2008 ValiRx plc (the 'Company') Result of General Meeting The Company confirms that the following resolutions put to shareholders at today's general meeting have been duly approved: 1. an ordinary resolution to increase the authorised share capital of the company from £5,100,000 to £7,200,000; 2. an ordinary resolution to authorise the Directors to allot relevant securities (as defined in section 80 of the Act) up to a maximum amount of £2,000,000; and 3. a special resolution to allow the Directors, subject to the limits set out in that resolution, to issue shares for cash on a non-pre-emptive basis, including a specific authority to allot shares up to an aggregate nominal amount of £2,000,000. Further to the announcment on 7 April 2008, application has been made for 7,473,332 new ordinary shares of 6p each in the Company ('Ordinary Shares'), issued via a placing at 6p per share ('Placing Shares'), to be admitted to trading on AIM and dealings are expected to commence on 6 May 2008 ('Admission '). On Admission, the Company will have 41,603,095 Ordinary Shares in issue. Attached to each Placing Share will be a warrant to subscribe for one new Ordinary Share at 10p per share for a period of three years from the admission of the Placing Shares to trading on AIM. Contact Details: ValiRx Plc WH Ireland Limited GTH Communications Dr Satu Vainikka David Youngman Toby Hall / Brooke Paul +44 (0) 203 008 4416 +44 (0) 161 832 2174 +44 (0) 20 7153 8035 This information is provided by RNS The company news service from the London Stock Exchange

Companies

Valirx (VAL)
UK 100